Business
RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales
ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly
About this update from Rxsight, Inc.
[{"type":"text","content":"ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice President of U.S. Sales. In this new position, Mr. Everly will lead the continued development and expansion of the company’s sales organization. “We are extremely excited to have Steve join RxSight® at this important time, as we build on the momentum of more than 130 practices experiencing the benefits of better medicine and better business offered by the Light Adjustable Lens, now featuring ActivShield™ technology,” said Eric Weinberg, Chief Commercial Officer of RxSight. “Steve’s deep industry relationships, decades of commercial experience and shared core values are a perfect fit for RxSight and we look forward to his contributions as we drive physician adoption of the Light Adjustable Lens system.” Most recently, Mr. Everly served as Johnson & Johnson Vision’s Area Vice President, Surgical Sales Western U.S., responsible for all aspects of Cataract, Refractive and Ocular Surface product sales. Prior to that Mr. Everly spent nine years in roles of increasing responsibility with Abbott Laboratories ultimately becoming Director, US Refractive Sales and nine years in commercial roles at Advanced Medical Optics, Inc. Forward-Looking StatementsThis press release contains forward-looking statements, including those related to the continued development and expansion of the company’s sales organization, the building of sales momentum, the benefits of better medicine and better business and physician adoption. Such statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements, and among other things, our ability to maintain cash balances and successfully commercialize or partner our product candidates currently under development. In some cases, you can identify forward-looking statements by terminology such as \"may,\" \"will,\" \"should,\" \"could,\" \"would,\" \"expects,\" \"plans,\" \"intends,\" \"anti...